Page last updated: 2024-10-16

5-hydroxytryptophan and Pulmonary Eosinophilia

5-hydroxytryptophan has been researched along with Pulmonary Eosinophilia in 1 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nau, F1
Miller, J1
Saravia, J1
Ahlert, T1
Yu, B1
Happel, KI1
Cormier, SA1
Nichols, CD1

Other Studies

1 other study available for 5-hydroxytryptophan and Pulmonary Eosinophilia

ArticleYear
Serotonin 5-HTâ‚‚ receptor activation prevents allergic asthma in a mouse model.
    American journal of physiology. Lung cellular and molecular physiology, 2015, Jan-15, Volume: 308, Issue:2

    Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactiv

2015